These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
507 related articles for article (PubMed ID: 33064859)
1. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders. Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of Synuclein- Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126 [TBL] [Abstract][Full Text] [Related]
3. Oral carcinogenesis and non-invasive biomarkers for the diagnosis of oral squamous cell carcinoma. Khan S; Alamgir MM J Pak Med Assoc; 2024 Feb; 74(2):370-373. PubMed ID: 38419239 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of synuclein-γ levels by novel monoclonal antibody in saliva and cancer tissues from oral squamous cell carcinoma patients. Wang K; Shen Y; Xu J; Li Z; Liu Y; Yu C; Peng L; Zheng J; Zeng Y Neoplasma; 2020 May; 67(3):707-713. PubMed ID: 32202903 [TBL] [Abstract][Full Text] [Related]
5. γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma. Cheng JC; Chiang MT; Lee CH; Liu SY; Chiu KC; Chou YT; Huang RY; Huang SM; Shieh YS J Dent Res; 2016 Apr; 95(4):439-45. PubMed ID: 26661712 [TBL] [Abstract][Full Text] [Related]
6. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis. Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587 [TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of soluble TIM-3 in oral squamous cell carcinoma. Lu K; Ma H; Wang T; Huang Y; Ru M Future Oncol; 2022 Jan; ():. PubMed ID: 35051343 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma. Yuan C; Yang K; Tang H; Chen D Onco Targets Ther; 2016; 9():3381-6. PubMed ID: 27350753 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders. Garg A; Urs AB; Koner BC; Augustine J; Guru SA Head Neck Pathol; 2023 Dec; 17(4):961-968. PubMed ID: 38015343 [TBL] [Abstract][Full Text] [Related]
10. Expression of Human Papillomavirus and the p16 Gene in Oral Potentially Malignant Disorders (OPMD): a Comparative Study With Oral Squamous Cell Carcinoma. Baddevithana AK; Jayasinghe RD; Tilakaratne WM; Illeperuma RP; Siriwardena BSMS Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):331-338. PubMed ID: 37036407 [TBL] [Abstract][Full Text] [Related]
11. Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches. Chu HW; Chang KP; Hsu CW; Chang IY; Liu HP; Chen YT; Wu CC Mol Cell Proteomics; 2019 Sep; 18(9):1796-1806. PubMed ID: 31253657 [TBL] [Abstract][Full Text] [Related]
12. Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma. Nakamichi E; Sakakura H; Mii S; Yamamoto N; Hibi H; Asai M; Takahashi M Oral Dis; 2021 Apr; 27(3):439-447. PubMed ID: 32688445 [TBL] [Abstract][Full Text] [Related]
13. A reappraisal of the squamous cell carcinoma antigen as a tumor marker in head and neck cancer. Snyderman CH; D'Amico F; Wagner R; Eibling DE Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1294-7. PubMed ID: 7576477 [TBL] [Abstract][Full Text] [Related]
14. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population. Gleber-Netto FO; Yakob M; Li F; Feng Z; Dai J; Kao HK; Chang YL; Chang KP; Wong DT Clin Cancer Res; 2016 Jul; 22(13):3340-7. PubMed ID: 26847061 [TBL] [Abstract][Full Text] [Related]
15. Improving the diagnostic efficacy of squamous cell carcinoma antigen for oral squamous cell carcinoma via saponin disruption of serum extracellular vesicles. Yang M; Ding J; Luo Q; Chen X; Chen F Clin Chim Acta; 2022 Jan; 525():40-45. PubMed ID: 34921893 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Cancer Stem Cell Markers in Potentially Malignant Disorders of Oral Mucosa: A Meta-analysis. Saluja TS; Ali M; Mishra P; Kumar V; Singh SK Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):144-153. PubMed ID: 30315141 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the levels of salivary paxillin in oral potentially malignant disorders and malignant lesions. Hussine AA; Selim K; Shaker O; Kamal Y BMC Oral Health; 2024 Jul; 24(1):834. PubMed ID: 39048985 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders. Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382 [TBL] [Abstract][Full Text] [Related]
19. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma. Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540 [TBL] [Abstract][Full Text] [Related]
20. Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan. Yu JS; Chen YT; Chiang WF; Hsiao YC; Chu LJ; See LC; Wu CS; Tu HT; Chen HW; Chen CC; Liao WC; Chang YT; Wu CC; Lin CY; Liu SY; Chiou ST; Chia SL; Chang KP; Chien CY; Chang SW; Chang CJ; Young JD; Pao CC; Chang YS; Hartwell LH Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11549-11554. PubMed ID: 27663741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]